Strengthening the R&D structure, including overseas subsidiaries
First written in FY2016. 8 of 12 entries say "Advanced", first in FY2018-Q3. Latest entry: FY2026.
25 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「Research and development for products sold outside Japan is conducted in Indonesia, Malaysia, Vietnam and Italy, in addition to Japan, and is being further strengthened.」
Research and development bases are identified in Japan, Southeast Asia and Europe, including Vietnam, giving concrete form to the regional expansion of research and development. - FY2024AdvancedAnnual report
「Research and development is conducted by the Company, PT. FUMAKILLA INDONESIA, Fumakilla Malaysia Berhad, FUMAKILLA EUROPE S.R.L, ZAPI INDUSTRIE CHIMICHE S.P.A., フマキラー・トータルシステム株式会社 and FSブルーム株式会社.」
Research and development activities are disclosed as spanning Japan, Southeast Asia, Europe and domestic subsidiaries, providing specifics on the actual operations of research and development bases, including 2 in Europe. - FY2023RestatedAnnual report
「Research and development for products sold outside Japan is conducted at development bases in Indonesia and Malaysia. At the new research and development building in Indonesia, Brains Park Indonesia, research and development outside Japan has been further strengthened through the use of the new facility. The establishment of FUMAKILLA EUROPE S.R.L and the acquisition of shares in Zapi Industrie Chimiche S.p.A. have also given us a development base in Europe.」
Reaffirming the policy of strengthening research and development outside Japan by using bases in Japan, Southeast Asia and Europe. - FY2022AdvancedAnnual report
「The establishment of FUMAKILLA EUROPE S.R.L and the acquisition of shares in Zapi Industrie Chimiche S.p.A. have given us a development base in Europe as well.」
In addition to the existing research and development structure in Japan and Southeast Asia, development bases have been established in Europe through the establishment of FUMAKILLA EUROPE S.R.L and the acquisition of Zapi as a subsidiary. - FY2022-Q3RestatedAnnual report
「The following major facilities planned as of the end of the previous consolidated fiscal year were completed during the cumulative third quarter of the current consolidated fiscal year.」
The completed research and development building at Brains Park, Hiroshima plant, and the research and development building and related facilities in Indonesia are listed again, confirming the development of the research and development structure, including overseas subsidiaries. - FY2022-Q1AdvancedAnnual report
「The following major facilities planned as of the end of the previous consolidated fiscal year were completed during the cumulative first quarter of the current consolidated fiscal year.」
The research and development building at Brains Park, Hiroshima plant, was completed in May 2021, and the research and development building and related facilities in Indonesia were completed in February 2021. The completion of these facilities demonstrates concrete progress in strengthening the research and development structure, including in Indonesia. - FY2021AdvancedAnnual report
「The new research and development building under construction in Indonesia has been completed and began operations in June. We will use this new facility to further strengthen research and development outside Japan.」
The research and development building in Indonesia was completed and began operations in June, demonstrating concrete progress. - FY2020SoftenedAnnual report
「PT. FUMAKILLA INDONESIA South Jakarta, Indonesia Research and development building and related facilities 480 306 Internal funds February 2018 October 2020」
The scheduled completion of the research and development building in Indonesia has been postponed from the previous target of August 2019 to October 2020. - FY2019AdvancedAnnual report
「From a global perspective, we are proceeding with the construction of Brains Park, a new development building and production facility at our Hiroshima plant, and a research and development building in Indonesia, to further strengthen the research and development structures of our overseas subsidiaries as well as in Japan and to achieve higher quality and lower costs than before.」
Construction of Brains Park at the Hiroshima plant and a research and development building in Indonesia is under way, giving concrete form to the strengthening of the research and development structure, including overseas subsidiaries. - FY2018AdvancedAnnual report
「Construction of a research and development building is under way at PT. FUMAKILLA INDONESIA.」
The plan for a research and development building and related facilities in Indonesia has taken concrete shape, with an investment of ¥480 million, work commencing in February 2018 and completion scheduled for August 2019. - FY2018-Q3AdvancedAnnual report
「We conducted a third-party allotment of new shares to Sumitomo Corporation Agro International Co., Ltd., a non-controlling shareholder, to fund the construction of a research and development building and related facilities in Indonesia. Following the capital increase, our ownership interest will be 80.0%, down from 85.0% before the capital increase.」
Regarding the strengthening of the research and development structure in Indonesia, a third-party allotment of new shares was conducted on 1 February 2018 to fund construction of a research and development building, demonstrating specific progress. - FY2016First statedAnnual report
「From a global perspective, we will strengthen the research and development structures of our overseas subsidiaries in Indonesia and Malaysia, as well as in Japan, and promote the development of products adapted to local needs and actual consumer usage in each country.」
Policy of strengthening research and development structures in Japan, Indonesia and Malaysia and developing products adapted to local markets.